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Information about the basic biological properties of human rhinovirus-C (HRV-C) viruses is lacking due
to difﬁculties with culturing these viruses. Our objective was to develop a cell culture system to grow
HRV-C. Epithelial cells from human sinuses (HSEC) were differentiated at air–liquid interface (ALI).
Differentiated cultures supported 1–2 logs growth of HRV-C15 as detected by quantitative RT-PCR.
Two distinguishing features of HRVs are acid lability and optimal growth at 33–34 1C. We used this
system to show that HRV-C15 is neutralized by low pH (4.5). In contrast to most HRV types, replication
of HRV-C15 and HRV-C41 was similar at 34 and 37 1C. The HSEC ALI provides a useful tool for
quantitative studies of HRV-C replication. The ability of HRV-C to grow equally well at 34 1C and 37 1C
may contribute to the propensity for HRV-C to cause lower airway illnesses in infants and children with
asthma.
& 2012 Elsevier Inc. All rights reserved.Introduction
Human rhinoviruses (HRV) are the causative agents of com-
mon cold and are the most frequent cause of acute respiratory
tract infection both in children and in adults (Arden et al., 2006;
Johnston et al., 1995; Nicholson et al., 1993). HRV have a
tremendous diversity and 160 subtypes have been recognized
so far. Historically, HRV were classiﬁed into 100 serotypes based
on cross-reactivity in neutralization tests (Hamparian et al.,
1987). These serotypes were categorized in a variety of ways
such as receptor usage into major or minor group (Uncapher et al.,
1991), or according to the sensitivity to antiviral agents into
group A or B (Andries et al., 1990). Based on the full-length or
partial (VP2/VP4 and VP1) coding sequences they were initially
classiﬁed into A and B genotypes (Ledford et al., 2004; Savolainen
et al., 2002). With the use of molecular diagnostic techniques a
novel group was discovered in 2006 (Arden et al., 2006) and was
designated C species. HRV-C are not emerging viruses (Arden and
Mackay, 2010) but had been circulating unnoticed due to the
inability to culture them. Sequencing of the complete genomes ofll rights reserved.
t of Pediatrics and Medicine,
isconsin, Madison,WI 53792,
n).A, B and available C types conﬁrmed their assignment into three
distinct phylogenetic taxa (Palmenberg et al., 2009).
HRV are associated with a broad range of clinical disease
including the common cold, bronchiolitis, pneumonia, wheezing
and asthma exacerbation especially in children (Arden et al.,
2010; Briese et al., 2008; Miller et al., 2009). There is some
evidence that HRV-C may be more virulent than other species
(Kaida et al., 2011; Mak et al., 2011). For example, HRV-C may be
more likely than HRV-B to cause more severe illnesses in infancy
(Lee et al., 2012), and HRV-C may be more likely than other
species to cause acute exacerbations of asthma (Bizzintino et al.,
2011; Fry et al., 2011). These ﬁndings, along with distinct genetic
features and use of alternative cell surface receptor(s) (Bochkov
et al., 2011), suggest that there may be important differences in
the replication cycle of HRV-C viruses compared to other HRV.
In fact, unlike HRV-A and HRV-B species, HRV-C could not be
propagated in standard cell culture. We previously reported
growth of an HRV-C isolate (HRV-C15) in organ cultures of human
sinus epithelium (HSEC) obtained as a byproduct of human sinus
surgeries (Bochkov et al., 2011). This system provided an impor-
tant tool for HRV-C research, however, tissue samples obtained
from patients are limited in amount and are difﬁcult to standar-
dize for quantitative research.
To overcome these limitations, we developed a system for
growing HRV-C in an air–liquid interface of differentiated human
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cilia and goblet cells, and used it to study some of the basic
biological properties of HRV-C. Two characteristics that distin-
guish HRV from human enteroviruses are their instability at low
pH and their optimal growth at 33–34 1C (Dimmock and Tyrrell,
1964; Taylor-Robinson and Tyrrell, 1962; Turner, 2007). We used
the HSEC ALI system to study the effects of low pH treatment and
to determine effects of temperature on replication of two differ-
ent HRV-C types.Results
Replication of HRV-C15 in different culture systems for sinus
epithelium
Following inoculation of sinus organ cultures with puriﬁed
HRV-C15 virions, the mean quantity of cell-associated HRV RNA
48–72 h post-inoculation (PI) increased by 1–1.5 log units
(P¼0.078; Fig. 2A). However, when these cells were grown in
undifferentiated monolayers, viral attachment was lower and
remained low over the next 48 h (P¼0.244; Fig. 2B). Next, we
tested HRV-C15 replication in epithelial cells from human sinus
epithelium (HSEC) differentiated under ALI conditions. Approxi-
mately two-thirds supported HRV-C15 replication (0.5–2 logs
increase in HRV RNA, Po0.05; Fig. 2C). HRV-C15 infection did
not cause notable cytopathic effects or changes to ciliary beating
(data not shown).
Comparison of HRV-C15 and HRV-A16 growth in ALI cultures
Following inoculation with HRV-C15 virions (2.0108 RNA
copies), 4.7105 HRV RNA copies were cell-associated, and 24 h
later the RNA had increased to 2.1107 RNA copies (P¼0.002;Fig. 2. Propagation of HRV-C15 in different forms of human sinus epithelium. (A) Pieces
copies) (n¼5), (B) dissociated into single cell suspension, passaged, and grown as a mo
dose of HRV-C15. Samples were incubated at 34 1C and tested immediately post-infec
Fig. 1. Photomicrograph of human sinus epithelium after differentiation at ALI
(Haemotoxylin & Eosin, 600 magniﬁcation).Fig.3) with slightly less viral RNA after 48 h. After inoculation
with the same dose of puriﬁed HRV-A16 virions, RNA concentra-
tion was greater just after inoculation (1.1107 RNA copies) and
also 24 h later (3.9108 RNA copies, P¼0.002). The growth
kinetics of infection and net increase in RNA (HRV-C15 1.6 log
increase, HRV-A16 1.5 log increase) among the two viruses were
similar.
In order to compare dose-related effects on virus replication,
HSEC ALI cultures were incubated with 103–108 RNA copies of
either HRV-C15 or HRV-A16 virions. For both viruses, there was a
1–2 logs increase in cell-associated HRV RNA over a broad range
of inoculating doses (Po0.05; Fig. 4A and B). The peak ampliﬁca-
tion occurred at the doses of 104–106 RNA copies per culture
(Fig. 4C). When normalized for the amount of viral binding, the
amounts of output HRV RNA 24 h PI were quite similar (Fig. 4D).Optimization of ALI cultures conditions for the ampliﬁcation
of HRV-C15
HRV-C15 replication was not altered by changing the concen-
tration of sodium bicarbonate (0.05%–0.235%), MgCl2 (0.7–30 mM),of human sinus mucosal tissue were either infected with HRV-C15 (2.8108 RNA
nolayer (n¼3) and (C) differentiated at ALI (n¼3) and then infected with the same
tion (PI) and again 48–72 h later for HRV RNA. *Po0.05.
Fig. 3. HRV infection of ALI cultures. HSEC ALI cultures (n¼6) at 21 days of age
were infected with HRV-C15 (2.0108 RNA copies) or HRV-A16 (3108 RNA
copies) at 34 1C. The cultures for cell-associated virus were collected at 4 h and for
recovered virus were incubated for 24–48 h post-infection (PI). *P¼0.001,
**Po0.005 compared to viral RNA post-inoculation.
Fig. 4. Dose response curve of HRV in differentiated HSEC. Differentiated HSEC cultures (n¼3) were infected with HRV-C15 or HRV-A16 virions serially diluted (5108–
5103 RNA copies per well), and cell-associated viral RNA was quantitated immediately post-inoculation (PI) and 24 h later. Panels (A) and (B) illustrate the relationship
between input virus, viral binding, and viral yield after 24 h for HRV-C15 and HRV-A16 respectively. These same data were replotted to illustrate the relationship between
inoculum dose and net increase in viral RNA (C), and the relationship between viral binding and viral yield for the two viruses (D). *Po0.05.
Fig. 5. Effect of age of culture on HRV-C15 replication. HSEC cultures (n¼3) were
allowed to differentiate for one or two months at ALI, and then were infected with
HRV-C15 (1108 RNA copies). Viral replication was measured after 24 h.
Differences in the baseline and replication levels of viral RNA between the 1 month
and 2 months cultures were determined by the t-test.*Po0.001.
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concentrations (0.8–40 nM) to optimize HSEC cell differentiation
and virus propagation. HSEC ALI cultures failed to grow and
differentiate in 0.8 nM and 10 nM EGF and 40 nM was the optimal
EGF concentration for optimal growth of the HSEC ALI cultures.
HRV-C15 replication was similar for EGF concentrations of 20 vs.
40 nM. Adsorption times of 1–4 h produced similar HRV-C15
binding and replication (data not shown).
To test the effects of duration of differentiation on HRV-C15
replication, we cultured HSEC at ALI for 1 month or 2 months and
then inoculated them with HRV-C15. Both RNA binding and
replication were signiﬁcantly higher in 2 month ALI cultures
compared to those infected after 1 month differentiation
(Po0.001, Fig. 5). TER values between 1 and 2 month old cultures
were similar (data not shown).
Effects of low pH
To determine if HRV-C15 infectivity is neutralized by low pH
as are other HRV, we treated the HRV-C15 with pH 4.5 and
assayed viral RNA replication in sinus organ cultures and in
Fig. 6. Sensitivity of HRV-C15 to low pH. HRV-C15 was diluted 1:10 in citrate phosphate buffer (pH¼4.5) or left untreated (pH 7.5), and was then used to infect (A) sinus
organ cultures (n¼3) (B) differentiated cultures of HSEC (n¼3). Similar experiments were conducted with HRV-A16 (C). Virus titers were determined 24 h after
inoculation. *Po0.05, **Po0.004 by t-test.
Fig. 7. Effect of temperature on HRV-C replication. (A) Differentiated cultures of HSEC (n¼3) were infected with HRV-C15 (1108 RNA copies), and viral RNA was
measured immediately post-inoculation and again after incubation at 33–37 1C for 24, 48 and 72 h. In separate experiments, differentiated HSEC were inoculated with
either HRV-C15 (2108 RNA copies, n¼5, panel B) or HRV-C41 (2107 RNA copies, n¼7, panel C) and viral RNA was determined after incubation at either 34 1C or 37 1C
for 24 h PI.
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abrogated replication in organ culture (Po0.05; Fig. 6A) and ALI
culture (Po0.05; Fig. 6B). These effects were similar to those of
low pH on HRV-A16 (P¼0.004; Fig. 6C).Optimum temperature for HRV-C15 growth
HRV-C15 replication over 24 h was tested at temperatures
ranging from 33 to 37 1C. HRV-C15 RNA increased by 1.5 logs after
24 h at all temperatures tested (Fig. 7A). We repeated the
experiments using two different HRV-C (puriﬁed C15 and C41
from cell lysates), and found that replication of both viruses was
similar at 34 1C and 37 1C (Fig. 7B and C).Discussion
HRV-C types are of great interest because of their association
with childhood pneumonia, wheezing illnesses and the common
cold, but not much is known about their biology because of
difﬁculties in culturing these viruses. HRV-C can be cultured in
human sinus organ culture, but quantitative research is difﬁcult
with this technique. Hence, in this study we developed a system
for differentiating sinus epithelium cells in ALI that supported
efﬁcient HRV-C replication. Using this system, we demonstrated
that HRV-C, like other HRV, is neutralized by low pH, but thatHRV-C15 and C41 differ from most HRV-A and HRV-B types in
replicating equally well at 33–34 1C and 37 1C.
HRV-C15 grows well in organ culture and in cells differen-
tiated at ALI, but not in sinus epithelial cells grown in a mono-
layer. The paucity of cell-associated RNA immediately after
inoculation indicates that the virus does not bind well to the
undifferentiated epithelial cells in the monolayer. This ﬁnding
indicates that the either the receptor is absent, or else the cells are
lacking a cofactor that promotes cellular binding. When the
cultures are re-differentiated, both binding and replication are
restored, possibly due to re-expression of the receptor.
In the differentiated cells, both HRV-C15 and HRV-A16 repli-
cated well over a broad range of doses (104 RNA copies–107 RNA
copies). Peak viral replication was achieved with inoculum size
between 104 and 106 RNA copies per sample. These ﬁndings
suggest that relatively low-dose inoculation produces the best
signal for studies of virus replication. If the goal is maximum
yield, such as production of viral stocks, more input virus would
be desirable.
For any given concentration of input virus, binding of HRV-A16
was greater than that of HRV-C15. This could be due to increased
expression of the receptor for HRV-A16 (i.e. ICAM-1), or perhaps a
higher afﬁnity of the HRV-A16 to its receptors as compared to
HRV-C15. Molecular modeling studies of HRV-C15 have predicted
a loss of mass at the 5-fold axis of symmetry, analogous to an
area associated with receptor binding in HRV-A and HRV-B
(Palmenberg et al., 2009). These changes could contribute to
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cells. Notably, replication of the two different strains was nearly
identical once the data were normalized for virus binding,
suggesting that replication processes distal to binding are similar.
The HSEC-ALI system for HRV-C replication has several advan-
tages over the organ culture. First, it allows for expansion of HSEC
before differentiation, thus providing more cells from the same
donor for testing of multiple conditions. Notably, stocks of
undifferentiated cells can be cryopreserved for use on multiple
days. In addition, the number of cells per well is uniform, and the
cultures consist almost entirely of epithelial cells which provides
a more uniform substrate for viral replication. Another group
published the growth of HRV-C15 in ALI system that agrees with
our ﬁndings (Hao et al., in press). These studies together demon-
strate that the HSEC-ALI system is advantageous for quantitative
studies of HRV-C biology, pathogenic mechanisms, and pre-
clinical tests of anti-viral drugs.
Growth of HRV-C15 in HSEC ALI cultures also enabled studies
of basic characteristics of the HRV-C types. HRVs are rendered
noninfectious by low pH, which causes a conformational change
in virus capsid resulting in a loss of VP4 and uncoating of the virus
(Giranda et al., 1992). This is a deﬁning property that distin-
guishes HRVs from the closely related enteroviruses. Our results
demonstrate that HRV-C strains, like HRV-A and HRV-B, are
sensitive to low pH.
One other notable characteristic is that most HRV grow
optimally at 33–34 1C and have reduced replication at 37 1C
(Schroth et al., 1999; Taylor-Robinson and Tyrrell, 1962; Tyrrell
and Parsons, 1960; Papadopoulos et al., 1999). Although the
mechanism of temperature sensitivity is not completely under-
stood, there has been a speculation that the lower GC content of
HRV compared to other enteroviruses is an adaptation for
replication at lower temperatures (McIntyre et al., 2010). Overall,
HRV-C genomes have a higher GþC content (43%) than HRV-A
and HRV-B (37% and 38%) and are closer to HEV (ranging from 42
to 48%) (Linsuwanon et al., 2011); this has led to speculation that
HRV-C might grow well at core body temperature. Our results
support this theory, since both HRV-C15 and another clinical
isolate (HRV-C41) grew equally well at 34 1C vs 37 1C. Additional
isolates of HRV-C and other species need to be tested in the future
to determine if the ability to grow well at 37 1C is a general and
distinct property of the C species.
This culture system has some advantages and some limitations
that should be considered. The ALI culture system yields polarized
cell layers that are morphologically similar to airway epithelium
in vivo. This system, unlike cell lines (e.g. MRC-5, HeLa and
WI-38) that are often used for HRV culture, supported the growth
of all three species of HRV, and could therefore enable studies of
comparative biology. One limitation of our studies is that viral
titer is inferred from the quantity of viral RNA and not by the
progeny virus particles produced since plaque assays for HRV-C
strains await development. Previous studies have demonstrated
excellent correlation between HRV measured by plaque assay and
by qPCR (Mosser et al., 2005). Addition of retinoic acid and
steroids in the ALI medium is essential for development and
differentiation of the HSEC epithelium. However, presence of
steroids in the culture medium could affect antiviral responses
and in turn virus replication. Further studies are needed to
decipher the role of such hormones and growth factors on HRV
replication in differentiated HSEC.
To summarize, we developed a culture system in which
clinical HRV-C strains can be grown and tested. This model
system serves as an important tool for studying HRV-C infections
and provides useful insights into the biological properties of
HRV-C strains. Ability to grow at a higher temperature may have
clinical implications, and could contribute to a greater propensityfor some HRV-C strains to cause lower airway syndromes such as
wheezing illnesses and exacerbations of asthma.Materials and methods
Viruses
HRV-A16 and HRV-C15 were clinical isolates that were cloned
and viruses were produced by transfecting viral RNA into Hela
cells as previously described (Bochkov et al., 2011). After three
freezes, thaw cycles the cell lysate was treated with RNaseA
(10 mg/ml) for 10 min at room temperature to get rid of free RNA
that is present outside the virions. This procedure was included so
that viral RNA measurements would reﬂect the quantity of
viruses and not unpackaged viral RNA. The viruses were puriﬁed
by pelleting through a 30% sucrose cushion in a Beckman SW 41
rotor (40,000 rpm, 16 1C, 130 min) (Lee et al., 1995; Wang et al.,
1998). Pelleted virus was resuspended in PBS with 0.01% BSA and
stored at 70 1C. HRV-C41 was a clinical isolate produced by
inoculating nasal secretions into sinus organ culture as previously
described (Bochkov et al., 2011). The cultures were frozen and
thawed thrice to release the virions and centrifuged at low speed
to get rid of the cellular debris and frozen at 70 1C till used.
RNA extraction and quantitative (q) RT-PCR
Total RNA was extracted from sinus tissue or ALI cultures
using the RNeasy Mini kit (Qiagen). HRV RNA concentrations were
determined by qRT-PCR as previously described (Bochkov et al.,
2011).
Sinus organ cultures
Sinus tissue was obtained from residual surgical specimens
from individuals undergoing sinus surgery (Bochkov et al., 2011)
and the protocol was approved by the University of Wisconsin-
Madison Human Subjects Committee. All samples were washed
thrice with PBS, cut in 44 mm2 pieces and then tested for
HRV, adenovirus, inﬂuenza, parainﬂuenza, enterovirus, respira-
tory syncytial virus, metapneumovirus, coronavirus and bocavirus
by multiplex PCR (Lee et al., 2007) before proceeding with
experiments.
Cultures of human sinus epithelium
To obtain sinus epithelial cells, the tissue was washed with
PBS and digested by pronase (Roche, Basel, Switzerland) and
DNase (Sigma–Aldrich, St.Louis, MO) (Schroth et al., 1999).
Epithelial cells were seeded in 75 cm2 CellBinds ﬂasks (Costar;
Corning Inc., Corning, NY) and cultured in Bronchial Epithelial
Growth Medium (BEGM, Lonza, Walkersville, MD). At 90% con-
ﬂuence, the cells were dissociated with trypsin and seeded either
as monolayer cultures or for differentiation at ALI. The cells
obtained at P-0 and P-1 were frozen in liquid nitrogen for future
use. For monolayers, cells were seeded into 12-well tissue culture
plates at a density of 1105 cells/ml. For differentiated cultures,
cells were seeded at a density of 1.5105 cells/cm2 in BEGM
(Lonza, Walkersville, MD) onto the apical surface of 1.13 cm2
Transwell polycarbonate inserts (Costar 0.4 mm pore size, 10 mm
membrane thickness; Corning Inc., Corning, NY) coated with
human placental collagen Type VI (Sigma–Aldrich, St.Louis, MO)
in a 12-well plate. The cells were fed basally with BEGM and
incubated at 37 1C for ﬁrst 24 h. Media was removed from the
apical surface and the basal medium was changed to BEGM and
Dulbecco’s modiﬁed Eagle’s medium (DMEM) in a 1:1 ratio
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transferrin, 5 mg/ml; recombinant epithelial growth factor,
0.25 ng/ml; hydrocortisone, 0.25 mg/ml; epinephrine, 0.25 mg/ml;
triiodothyronine, 3.25 ng/ml; retinoic acid, 0.05 ng/ml; bovine
pituitary extract, 1% (v/v); gentamycin, 50 mg/ml (‘‘ALI’’ medium)
(Gray et al., 1996). The medium was replaced daily for the ﬁrst
seven days and every other day thereafter. The cultures were
allowed to mature for at least 21 days until ciliary movement
was visualized. The cultures exhibited trans-epithelial resistance
(TER) values from 800–1200 O/cm2 at 21 days consistent with
formation of tight junctions. The cultures on average contained
1106 cells/well at 30 days of age and formed a pseudo-stratiﬁed
epithelium (Fig. 1). Tissues from a total of 13 donors were tested,
and all except one differentiated in the ALI conditions.
HRV inoculation
Once the epithelial cells had differentiated, the medium was
removed and cells were washed thrice with PBS. Aliquots of
HRV-C15, HRV-C41 or HRV-A16 were diluted in BEGM/0.01% BSA to
a desired concentration and a 100 ml inoculum was added either to
the apical surface of the ALI culture, to the monolayer or to the
dissociated cells in suspension. The cultures were gently shaken
(15min, RT) and then incubated with virus at 34 1C for 1–4 h.
The cultures were washed at the apical surface thrice with PBS
(Ca and Mg free) and samples to assess cell-associated virus were
collected in 350 ml RLT buffer (Qiagen). The remaining samples were
fed basally with 1ml of ALI medium while dissociated cells were
plated in a 12-well plate and incubated (34–37 1C) for 24–72 h. After
aspirating the medium, cells were collected in 350 ml of RLT buffer
(Qiagen) for RNA extraction and qRT-PCR analysis.
Acid lability of HRV-C15
Puriﬁed HRV-C15 and HRV-A16 were diluted 1:10 in 0.15 M
citrate buffer (pH¼4.5) for 15 min at room temperature. The pH
treated and untreated viruses (1108 RNA copies) were used to
infect different pieces of sinus organ cultures or ALI cultures.
Statistical analysis
Student’s t-test was used to analyze viral replication between
two groups (in the Figs. 1–7) using SigmaPlot 11.0 (Systat Inc., San
Jose, CA), and Po0.05 was considered signiﬁcant.Acknowledgments
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